Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Clinical Therapeutics

Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

Christopher Lucasti, Liviu Vasile, Dorel Sandesc, Donatas Venskutonis, Patrick McLeroth, Mallika Lala, Matthew L. Rizk, Michelle L. Brown, Maria C. Losada, Alison Pedley, Nicholas A. Kartsonis, Amanda Paschke
Christopher Lucasti
aSouth Jersey Infectious Disease, Somers Point, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liviu Vasile
bUniversity of Medicine & Pharmacy, Craiova, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorel Sandesc
cUniversity of Medicine & Pharmacy, Timisoara, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donatas Venskutonis
dLithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick McLeroth
eCovance Inc., Princeton, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mallika Lala
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew L. Rizk
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle L. Brown
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria C. Losada
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Pedley
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas A. Kartsonis
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Paschke
fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00633-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.00633-16
PubMed 
27503659

Published By 
American Society for Microbiology Journals
History 
  • Received April 6, 2016
  • Returned for modification April 28, 2016
  • Accepted July 31, 2016
  • Published online September 23, 2016.

Copyright & Usage 
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Article Versions

  • Accepted Manuscript version (August 08, 2016).
  • You are viewing the most recent version of this article.

Author Information

  1. Christopher Lucastia,
  2. Liviu Vasileb,
  3. Dorel Sandescc,
  4. Donatas Venskutonisd,
  5. Patrick McLerothe,
  6. Mallika Lalaf,
  7. Matthew L. Rizkf,
  8. Michelle L. Brownf,
  9. Maria C. Losadaf,
  10. Alison Pedleyf,
  11. Nicholas A. Kartsonisf and
  12. Amanda Paschkef
  1. aSouth Jersey Infectious Disease, Somers Point, New Jersey, USA
  2. bUniversity of Medicine & Pharmacy, Craiova, Romania
  3. cUniversity of Medicine & Pharmacy, Timisoara, Romania
  4. dLithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania
  5. eCovance Inc., Princeton, New Jersey, USA
  6. fMerck & Co., Inc., Kenilworth, New Jersey, USA
  • Address correspondence to Amanda Paschke, amanda.paschke{at}merck.com.
  • Citation Lucasti C, Vasile L, Sandesc D, Venskutonis D, McLeroth P, Lala M, Rizk ML, Brown ML, Losada MC, Pedley A, Kartsonis NA, Paschke A. 2016. Phase 2, dose-ranging study of relebactam with imipenem-cilastatin in subjects with complicated intra-abdominal infection. Antimicrob Agents Chemother 60:6234–6243. doi:10.1128/AAC.00633-16.

Article usage

Article usage: August 2016 to February 2021

Rendering graph...
AbstractFullPdf
Aug 2016706053
Sep 20164561481
Oct 20163343167
Nov 20161672541
Dec 201676815
Jan 2017951326
Feb 2017106717
Mar 201784231
Apr 201778417
May 201769724
Jun 201750419
Jul 2017593041
Aug 2017411224
Sep 2017361324
Oct 2017491833
Nov 2017401029
Dec 201717179
Jan 2018352110
Feb 2018351011
Mar 2018412218
Apr 2018352315
May 2018402129
Jun 2018372016
Jul 2018644932
Aug 2018283112
Sep 201833319
Oct 2018153115
Nov 201824227
Dec 20180249
Jan 201914417
Feb 201972410
Mar 201973527
Apr 201933716
May 201974024
Jun 201975618
Jul 2019814350
Aug 20192010455
Sep 201947638
Oct 2019108443
Nov 201959848
Dec 201976125
Jan 202075856
Feb 202088040
Mar 202058844
Apr 202055143
May 20201110339
Jun 202077846
Jul 20202616073
Aug 202044121
Sep 202097235
Oct 2020118230
Nov 2020107039
Dec 2020117442
Jan 202187143
Feb 202145026
PreviousNext
Back to top
Download PDF
Citation Tools
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
Christopher Lucasti, Liviu Vasile, Dorel Sandesc, Donatas Venskutonis, Patrick McLeroth, Mallika Lala, Matthew L. Rizk, Michelle L. Brown, Maria C. Losada, Alison Pedley, Nicholas A. Kartsonis, Amanda Paschke
Antimicrobial Agents and Chemotherapy Sep 2016, 60 (10) 6234-6243; DOI: 10.1128/AAC.00633-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
Christopher Lucasti, Liviu Vasile, Dorel Sandesc, Donatas Venskutonis, Patrick McLeroth, Mallika Lala, Matthew L. Rizk, Michelle L. Brown, Maria C. Losada, Alison Pedley, Nicholas A. Kartsonis, Amanda Paschke
Antimicrobial Agents and Chemotherapy Sep 2016, 60 (10) 6234-6243; DOI: 10.1128/AAC.00633-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596